Discontinued — last reported Q4 '17
Indefinite-Lived Research and Development Assets
Zoetis Indefinite-Lived Research and Development Assets decreased by 1.4% to $214.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.4%, from $207.00M to $214.00M. Over 5 years (FY 2020 to FY 2025), Indefinite-Lived Research and Development Assets shows relatively stable performance with a 1.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates active investment in future technology, while a decrease may signal project completion or impairment.
Detailed definition
These are acquired in-process research and development (IPR&D) projects that have not yet reached technological feasibil...
Peer comparison
Common in technology and pharmaceutical sectors following M&A activity.
indefinite_lived_rd_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $199.00M | $199.00M | $186.00M | $171.00M | $175.00M | $174.00M | $175.00M | $175.00M | $107.00M | $240.00M | $236.00M | $236.00M | $215.00M | $214.00M | $209.00M | $207.00M | $217.00M | $216.00M | $217.00M | $214.00M |
| QoQ Change | — | +0.0% | -6.5% | -8.1% | +2.3% | -0.6% | +0.6% | +0.0% | -38.9% | +124.3% | -1.7% | +0.0% | -8.9% | -0.5% | -2.3% | -1.0% | +4.8% | -0.5% | +0.5% | -1.4% |
| YoY Change | — | — | — | — | -12.1% | -12.6% | -5.9% | +2.3% | -38.9% | +37.9% | +34.9% | +34.9% | +100.9% | -10.8% | -11.4% | -12.3% | +0.9% | +0.9% | +3.8% | +3.4% |
Indefinite-Lived Research and Development Assets at Other Companies
Frequently Asked Questions
- What is Zoetis's indefinite-lived research and development assets?
- Zoetis (ZTS) reported indefinite-lived research and development assets of $214.00M in Q1 2026.
- How has Zoetis's indefinite-lived research and development assets changed year-over-year?
- Zoetis's indefinite-lived research and development assets increased by 3.4% year-over-year, from $207.00M to $214.00M.
- What is the long-term trend for Zoetis's indefinite-lived research and development assets?
- Over 5 years (2020 to 2025), Zoetis's indefinite-lived research and development assets has grown at a 1.7% compound annual growth rate (CAGR), from $199.00M to $217.00M.
- What does indefinite-lived research and development assets mean?
- The value of research projects acquired from other companies that are still in progress.